Aclarion Inc
Company Profile
Business description
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient's low back pain, giving physicians clarity to optimize treatment strategies.
Contact
8181 Arista Place
Suite 100
BroomfieldCO80021
USAT: +1 833 275-2266
Sector
Healthcare
Stock type
Defensive
Industry
Health Information Services
Fiscal Year End
31 December 2026
Employees
11
Stocks News & Analysis
stocks
Steep downgrade for wide moat share
stocks
The strange effect of the 30% minimum capital gains tax
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,899.90 | 40.70 | -0.46% |
| CAC 40 | 8,436.24 | 43.63 | -0.51% |
| DAX 40 | 25,465.25 | 352.64 | -1.37% |
| Dow JONES (US) | 52,925.15 | 130.76 | -0.25% |
| FTSE 100 | 10,665.88 | 14.11 | 0.13% |
| HKSE | 23,855.75 | 358.86 | 1.53% |
| NASDAQ | 25,818.69 | 302.47 | -1.16% |
| Nikkei 225 | 67,882.84 | 374.12 | -0.55% |
| NZX 50 Index | 13,662.86 | 99.93 | -0.73% |
| S&P 500 | 7,503.85 | 33.58 | -0.45% |
| S&P/ASX 200 | 8,701.80 | 35.80 | -0.41% |
| SSE Composite Index | 3,993.88 | 3.64 | 0.09% |